World Health Organization, Pakistan Country Office, Chak Shehzad, Islamabad, Pakistan.
National Institute of Health, Chak Shehzad, Islamabad, Pakistan.
J Infect Public Health. 2020 Mar;13(3):438-445. doi: 10.1016/j.jiph.2019.05.014. Epub 2019 Jun 20.
Data on the viral etiology of acute lower respiratory infections are scarce in Pakistan. Human respiratory syncytial virus (RSV) is an important cause of morbidity in children but no effective vaccine or antiviral therapy is currently available. As vaccines are expected to become available in the future, it is important to understand the epidemiology of locally prevalent RSV subtypes. This study aimed to define the molecular epidemiology of RSV (A and B) genotypes in Pakistani children under 5 years.
World Health Organization case definitions for influenza-like illness (ILI) and severe acute respiratory illness (SARI) were used for case selection. Children under 5 years who presented with ILI or SARI at tertiary care hospitals from all provinces/regions, including the eight influenza sentinel sites, during October-April each year between 2010 and 2013 were enrolled. Demographic and clinical data of the children were recorded and nasopharyngeal/throat swabs taken for analysis. All samples were tested for RSV A and B using real-time polymerase chain reaction for non-influenza respiratory viruses. Specific oligonucleotide primers for RSV A and B were used for subtyping and sequencing of the G protein, followed by phylogenetic analysis.
A total of 1941 samples were included. RSV was detected in 472 (24%) children, with RSV A detected in 367 (78%) and RSV B in 105 (22%). The G protein of all RSV A strains clustered in the NA1/GA2 genotype while RSV B strains carried the signature 60 nucleotide duplication and were assigned to three BA genotypes: BA-9, BA-10 and the new BA-13 genotype.
This study highlights the importance of RSV as a viral etiologic agent of acute respiratory infections in children in Pakistan, and the diversity of RSV viruses. Continued molecular surveillance for early detection of prevalent and newly emerging genotypes is needed to understand the epidemiology of RSV infections in Pakistan.
在巴基斯坦,有关急性下呼吸道感染的病毒病因的数据很少。人类呼吸道合胞病毒(RSV)是儿童发病的重要原因,但目前尚无有效的疫苗或抗病毒疗法。由于预计未来会有疫苗问世,因此了解当地流行的 RSV 亚型的流行病学情况非常重要。本研究旨在确定巴基斯坦 5 岁以下儿童中 RSV(A 和 B)基因型的分子流行病学情况。
使用世界卫生组织(WHO)对流感样疾病(ILI)和严重急性呼吸道感染(SARI)的病例定义进行病例选择。2010 年至 2013 年期间,每年 10 月至 4 月,在所有省份/地区(包括 8 个流感哨点)的三级保健医院,对患有 ILI 或 SARI 的 5 岁以下儿童进行病例纳入。记录儿童的人口统计学和临床数据,并采集鼻咽/咽喉拭子进行分析。使用用于非流感呼吸道病毒的实时聚合酶链反应(PCR)对所有样本进行 RSV A 和 B 的检测。使用针对 RSV A 和 B 的特异性寡核苷酸引物进行 G 蛋白的亚型分析和测序,随后进行系统发育分析。
共纳入 1941 个样本。在 472 名(24%)儿童中检测到 RSV,其中 RSV A 为 367 名(78%),RSV B 为 105 名(22%)。所有 RSV A 株的 G 蛋白均聚类在 NA1/GA2 基因型中,而 RSV B 株则携带 60 个核苷酸的特征性重复序列,分为 3 种 BA 基因型:BA-9、BA-10 和新的 BA-13 基因型。
本研究强调了 RSV 作为巴基斯坦儿童急性呼吸道感染的病毒病因的重要性,以及 RSV 病毒的多样性。需要进行持续的分子监测,以早期发现流行和新出现的基因型,从而了解 RSV 感染在巴基斯坦的流行病学情况。